BioSpace News Archive

Biotech Bay

CymaBay Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

CymaBay Therapeutics, Inc. today announced that management will participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ.

April 17, 2023

·

2 min read

Pharm Country

Indaptus Therapeutics Receives Brazilian Patent Allowance for Decoy Platform

Indaptus Therapeutics, Inc. today announces it has received a patent allowance on Application #1120150158323 from the National Institute of Industrial Property of Brazil for its Decoy immunotherapy platform.

April 17, 2023

·

6 min read

Business

electroCore Provides Select First Quarter 2023 Financial Guidance

electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today provided select preliminary unaudited financial guidance for the first quarter of 2023.

April 17, 2023

·

4 min read

Genetown

$134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and Oncology

Ocean Biomedical, Inc., a biopharma company working to accelerate the development and commercialization of scientifically compelling assets from research universities and medical centers, shared an update on key company activities.

April 17, 2023

·

13 min read

Business

Cognito Therapeutics Announces Key Medical and Technology Leadership Appointments as Late-Stage Neurotechnology Platform Advances

Cognito Therapeutics , today announced executive leadership team appointments with Ralph Kern, M.D., as Chief Medical Officer and Kim Kwan as Chief Technology Officer who has been promoted from VP of Engineering.

April 17, 2023

·

3 min read

Biotech Bay

Scilex Holding Company Enters into Master Distributor Agreement with CH Trading Group LLC and AD Ports Group for the Distribution of ZTlido® in the Middle East and North Africa Region

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. announced a master distributor agreement with AD Ports Logistics, a subsidiary of the Logistics Cluster, AD Ports Group, a leading global facilitator of trade, logistics and industry based in Abu Dhabi.

April 17, 2023

·

9 min read

Drug Development

Tempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting

Tempest Therapeutics, Inc. announced that new data from its TPST-1120 and TREX1 programs were highlighted in two poster presentations at the 2023 American Association for Cancer Research Annual Meeting taking place April 14-19, 2023 in Orlando, FL.

April 17, 2023

·

6 min read

BioCapital

Precigen Presents Preclinical Data for the Next Generation Mesothelin UltraCAR-T® with Intrinsic PD-1 Blockade at the AACR Annual Meeting 2023

Precigen, Inc. (Nasdaq: PGEN) today presents preclinical data for the next generation UltraCAR-T platform utilizing MSLN CAR from Precigen’s library of non-viral plasmids at the American Association for Cancer Research (AACR) Annual Meeting 2023.

April 17, 2023

·

10 min read

Drug Development

Imvax Presents New Data at AACR 2023 Supporting the Mechanism of Action of its Lead Program, IGV-001, for Glioblastoma

Imvax, Inc. today announced a poster presentation providing additional mechanistic insights into its Goldspire™ platform based on preclinical studies of its lead product candidate, IGV-001, for the treatment of glioblastoma (GBM).

April 17, 2023

·

3 min read

BioMidwest

Smart Meter Debuts Three Proprietary Cellular-Enabled, Patient-Friendly Health Monitoring Solutions Purpose-Built for Remote Patient Monitoring at HIMSS Global Conference

Smart Meter, the number one supplier of remote patient monitoring devices, data, and services, supporting a nationwide network of SmartPartners, announces three new products at the HIMSS Global Conference in Chicago.

April 17, 2023

·

4 min read